Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Mining Chemicals Industry Research Report 2026: Tighter Water Rules and Bio-Based Collectors Drive Change, While Dry Processing Disrupts Reagent Use – Growth Forecasts 2025-2031

February 9, 2026

New Rally House Location on Chestnut St

February 9, 2026

iQor Appoints Colleen Beers as Chief Growth Officer

February 9, 2026

OneTrust Appoints John Heyman as Chief Executive Officer to Drive AI-Ready Governance Platform™ Innovation

February 9, 2026

NCH Rooney Heart Institute Recognized as One of Modern Healthcare’s Top 50 Cardiovascular Hospitals

February 9, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » First Intervention Shown to Lower Alzheimer’s and Dementia Incidence
Press Release

First Intervention Shown to Lower Alzheimer’s and Dementia Incidence

By News RoomFebruary 9, 20265 Mins Read
First Intervention Shown to Lower Alzheimer’s and Dementia Incidence
Share
Facebook Twitter LinkedIn Pinterest Email
First Intervention Shown to Lower Alzheimer’s and Dementia Incidence

SAN FRANCISCO, Feb. 09, 2026 (GLOBE NEWSWIRE) — In a world’s first, an NIH-funded randomized controlled trial of more than 2,800 older adults (the “ACTIVE Study”) has reported a modest amount of cognitive training significantly reduced Alzheimer Disease and related dementias diagnoses, as reported in Medicare data over a 20-year follow-up period. The results are published in Alzheimer’s & Dementia: Translational Research & Clinical Interventions, a journal of the Alzheimer’s Association. The brain training exercise that achieved these results is referred to in the study as “speed training,” and is available exclusively as part of the brain fitness app, BrainHQ from Posit Science.

“This is an astonishing result, and it comes at a critical time,” observed Dr. Henry Mahncke, CEO of Posit Science. “The number of people affected by Alzheimer’s keeps growing; new expensive drugs only slightly slow the rate of decline; and while observational studies suggest lifestyle changes can reduce Alzheimer’s risk, people aren’t sure which specific actions to take. These results change what’s possible — now — for better brain health and Alzheimer’s prevention, by demonstrating a specific type of cognitive training reduces the incidence of dementia reported in Medicare data over decades – an impeccable outcome measure. No other type of intervention – physical exercise, diet, nor other brain training – has shown such evidence.”

The ACTIVE Study randomized healthy older adults (average age 74, at the study start) into four groups: a speed training group, a reasoning training group, a memory training group, and a control group. All participants were extensively examined using standard neuropsychological and gerontological measures before the study began, and at years 1, 2, 3, 5, and 10. This 20-year study is based on Alzheimer’s and related dementias diagnoses in Medicare records.

Each training group was asked to complete a 60-75 minute training session, twice weekly, for the first five weeks of the study. A subset of each training group was then asked to complete “booster sessions” – 4 more sessions, both in month 11 and month 35, for a grand total of less than 23 hours (10 to 22.5 hours) spread over the initial three years of the 20-year study).

The study found that there was no significant effect from either the memory or reasoning training; however, those who were in the booster speed training group showed a significant (25%) reduction in diagnosed cases of dementia over the 20-year period.

“The two key results are that the benefit was unique to speed training – not all forms of cognitive activity worked – and that a modest amount of training was enough to drive significant benefit over two decades,” Dr. Mahncke added. “We’ve seen significant results across hundreds of studies of BrainHQ, which have consistently shown differences between speed-based, progressively-challenging brain training and other forms of general cognitive activity.”

The speed exercise was developed by Dr. Karlene Ball, University Professor at the University of Alabama Birmingham, and Dr. Dan Roenker, Professor Emeritus at Western Kentucky University, and is licensed exclusively to BrainHQ.

“We developed speed training to make brains faster because we knew that speed is fundamental to cognitive performance,” said Dr. Ball. “ACTIVE has proven that, across numerous studies, showing that speed training results in better mental health (depression, health-related quality of life, and greater confidence and control), better real-world function (functional independence, balance, gait, reaction time, driving) and now – lower risk for Alzheimer’s and dementia.”

“Working with scientists like Karlene, Dan and the ACTIVE team — and the thousands who have worked with us in designing, testing and validating these brain-plasticity-based training exercises — has changed the course of science,” said Dr. Michael Merzenich, UCSF Professor Emeritus, Kavli Laureate in Neuroscience, and the chief scientist behind BrainHQ. “The future of brain health is using an app to monitor and improve your physical and functional brain health. With these results, we’ve arrived at that future, and it’s an amazing moment.”

Dr. Merzenich is credited with discovering lifelong neuroplasticity and for first harnessing it in his co-invention of the cochlear implant (restoring hearing to millions), before turning his attention to creating computerized brain exercises to drive physical and functional brain health. He inspired the recent widely-covered INHANCE Study, in which BrainHQ exercises became the first intervention shown to cause the human brain to upregulate the production of acetylcholine (the “pay attention” chemical) — known to downregulate with aging and to plummet with dementia — providing an explanation of the biochemical mechanism of action behind these ACTIVE results.

BrainHQ has shown benefits in more than 300 studies. Such benefits include gains in cognition (attention, speed, memory, decision-making), in quality of life (depressive symptoms, confidence and control, health-related quality of life) and in real-world activities (health outcomes, balance, driving, workplace activities). BrainHQ is used by leading health plans, medical centers, clinics, and communities, and by elite athletes, the military, and other organizations focused on peak performance. Consumers can try a BrainHQ exercise for free daily at https://www.brainhq.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/bc627fa3-8532-4dcb-961e-0b772d26689f

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Mining Chemicals Industry Research Report 2026: Tighter Water Rules and Bio-Based Collectors Drive Change, While Dry Processing Disrupts Reagent Use – Growth Forecasts 2025-2031

New Rally House Location on Chestnut St

iQor Appoints Colleen Beers as Chief Growth Officer

OneTrust Appoints John Heyman as Chief Executive Officer to Drive AI-Ready Governance Platform™ Innovation

NCH Rooney Heart Institute Recognized as One of Modern Healthcare’s Top 50 Cardiovascular Hospitals

S2G Energy and AMPECO Power One Of Latin America’s Largest Electric Fleets

India Full-Truck-Load (FTL) Industry Report 2026: Expansion of Dedicated Freight Corridors, Surge in Organized Retail and E-Commerce Shipments Driving Growth – Growth Forecasts 2025-2031

Disclosure Management (DM) Research Report 2026: Rising Compliance Complexity Across Multi-Format, Multi-Jurisdiction Filings Bolster Expansion – Market Trends, Statistics, Forecasts 2025-2031

Donerail Issues Open Letter to MarineMax Shareholders

Editors Picks

New Rally House Location on Chestnut St

February 9, 2026

iQor Appoints Colleen Beers as Chief Growth Officer

February 9, 2026

OneTrust Appoints John Heyman as Chief Executive Officer to Drive AI-Ready Governance Platform™ Innovation

February 9, 2026

NCH Rooney Heart Institute Recognized as One of Modern Healthcare’s Top 50 Cardiovascular Hospitals

February 9, 2026

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

5 things to know about Halifax’s proposed new transit plan

February 9, 2026

S2G Energy and AMPECO Power One Of Latin America’s Largest Electric Fleets

February 9, 2026

Canada’s Oldham wins slopestyle bronze

February 9, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version